These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35277654)

  • 1. Preferences for return of germline genome sequencing results for cancer patients and their genetic relatives in a research setting.
    Best MC; Butow P; Savard J; Jacobs C; Bartley N; Davies G; Napier CE; Ballinger ML; Thomas DM; Biesecker B; Tucker KM; Juraskova I; Meiser B; Schlub T; Newson AJ
    Eur J Hum Genet; 2022 Aug; 30(8):930-937. PubMed ID: 35277654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological predictors of cancer patients' and their relatives' attitudes towards the return of genomic sequencing results.
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Best MC;
    Eur J Med Genet; 2022 Jun; 65(6):104516. PubMed ID: 35487418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PiGeOn project: protocol of a longitudinal study examining psychosocial and ethical issues and outcomes in germline genomic sequencing for cancer.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):454. PubMed ID: 29685123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of whole-genome sequencing to Australian cancer patients and their first-degree relatives participating in a genomic sequencing study.
    Butow P; Davies G; Napier CE; Bartley N; Ballinger ML; Biesecker B; Juraskova I; Meiser B; Schlub T; Thomas DM; Goldstein D; Best MC;
    J Genet Couns; 2022 Feb; 31(1):96-108. PubMed ID: 34218500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should access germline genome sequencing? A mixed methods study of patient views.
    Best MC; Butow P; Jacobs C; Savard J; Biesecker B; Ballinger ML; Bartley N; Davies G; Napier CE; Smit AK; Thomas DM; Newson AJ;
    Clin Genet; 2020 Feb; 97(2):329-337. PubMed ID: 31674008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer patient knowledge about and behavioral intentions after germline genome sequencing.
    Napier CE; Davies G; Butow PN; Schlub TE; Best MC; Bartley N; Juraskova I; Meiser B; Tucker KM; Biesecker BB; Thomas DM; Ballinger ML;
    Patient Educ Couns; 2022 Mar; 105(3):707-718. PubMed ID: 34247865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychological predictors of advanced cancer patients' preferences for return of results from comprehensive tumor genomic profiling.
    Meiser B; Butow P; Davies G; Napier CE; Schlub TE; Bartley N; Juraskova I; Ballinger ML; Thomas DM; Tucker K; Goldstein D; Biesecker BB; Best MC;
    Am J Med Genet A; 2022 Mar; 188(3):725-734. PubMed ID: 34755933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferences of Italian patients for return of secondary findings from clinical genome/exome sequencing.
    Godino L; Varesco L; Bruno W; Bruzzone C; Battistuzzi L; Franiuk M; Miccoli S; Bertonazzi B; Graziano C; Seri M; Turchetti D
    J Genet Couns; 2021 Jun; 30(3):665-675. PubMed ID: 33142017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should Researchers Offer Results to Family Members of Cancer Biobank Participants? A Mixed-Methods Study of Proband and Family Preferences.
    Gordon DR; Radecki Breitkopf C; Robinson M; Petersen WO; Egginton JS; Chaffee KG; Petersen GM; Wolf SM; Koenig BA
    AJOB Empir Bioeth; 2019; 10(1):1-22. PubMed ID: 30596322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced cancer patient preferences for receiving molecular profiling results.
    Best M; Butow P; Jacobs C; Juraskova I; Savard J; Meiser B; Goldstein D; Ballinger M; Bartley N; Napier C; Davies G; Thomas D; Tucker K; Schlub T; Newson AJ;
    Psychooncology; 2020 Oct; 29(10):1533-1539. PubMed ID: 32544291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pursuing germline genome sequencing to reduce illness uncertainty may involve additional uncertainties for cancer patients: A mixed-methods study.
    Bartley N; Best M; Butow P
    J Genet Couns; 2021 Aug; 30(4):1143-1155. PubMed ID: 33786948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The personal utility and uptake of genomic sequencing in pediatric and adult conditions: eliciting societal preferences with three discrete choice experiments.
    Goranitis I; Best S; Christodoulou J; Stark Z; Boughtwood T
    Genet Med; 2020 Aug; 22(8):1311-1319. PubMed ID: 32371919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors.
    Kaphingst KA; Ivanovich J; Lyons S; Biesecker B; Dresser R; Elrick A; Matsen C; Goodman M
    Transl Behav Med; 2018 Jan; 8(1):71-79. PubMed ID: 29385583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PiGeOn project: protocol for a longitudinal study examining psychosocial, behavioural and ethical issues and outcomes in cancer tumour genomic profiling.
    Best M; Newson AJ; Meiser B; Juraskova I; Goldstein D; Tucker K; Ballinger ML; Hess D; Schlub TE; Biesecker B; Vines R; Vines K; Thomas D; Young MA; Savard J; Jacobs C; Butow P
    BMC Cancer; 2018 Apr; 18(1):389. PubMed ID: 29621994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information Topics of Greatest Interest for Return of Genome Sequencing Results among Women Diagnosed with Breast Cancer at a Young Age.
    Seo J; Ivanovich J; Goodman MS; Biesecker BB; Kaphingst KA
    J Genet Couns; 2017 Jun; 26(3):511-521. PubMed ID: 27542972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life drives patients' preferences for secondary findings from genomic sequencing.
    Mighton C; Carlsson L; Clausen M; Casalino S; Shickh S; McCuaig L; Joshi E; Panchal S; Semotiuk K; Ott K; Elser C; Eisen A; Kim RH; Lerner-Ellis J; Carroll JC; Glogowski E; Schrader K; Bombard Y;
    Eur J Hum Genet; 2020 Sep; 28(9):1178-1186. PubMed ID: 32424322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome sequencing among children with medical complexity: What constitutes value from parents' perspective?
    Lee W; Luca S; Costain G; Snell M; Marano M; Curtis M; Dunsmore K; Veenma D; Walker S; Cohn RD; Marshall CR; Cohen E; Meyn MS; Orkin J; Hayeems RZ
    J Genet Couns; 2022 Apr; 31(2):523-533. PubMed ID: 34674352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer.
    Bijlsma R; Wouters R; Wessels H; Sleijfer S; Beerepoot L; Ten Bokkel Huinink D; Cruijsen H; Heijns J; Lolkema MP; Steeghs N; van Voorthuizen T; Vulink A; Witteveen E; Ausems M; Bredenoord A; May AM; Voest E
    ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32312756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes Toward Return of Genetic Research Results to Relatives, Including After Death: Comparison of Cancer Probands, Blood Relatives, and Spouse/Partners.
    Radecki Breitkopf C; Wolf SM; Chaffee KG; Robinson ME; Lindor NM; Gordon DR; Koenig BA; Petersen GM
    J Empir Res Hum Res Ethics; 2018 Jul; 13(3):295-304. PubMed ID: 29701109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer patients' views and understanding of genome sequencing: a qualitative study.
    Bartley N; Best M; Jacobs C; Juraskova I; Newson AJ; Savard J; Meiser B; Ballinger ML; Thomas DM; Biesecker B; Butow P
    J Med Genet; 2020 Oct; 57(10):671-676. PubMed ID: 31980566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.